EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - Results and commentary

M. Sant, T. Aareleid, F. Berrino, M. Bielska Lasota, P. M. Carli, J. Faivre, P. Grosclaude, G. Hédelin, T. Matsuda, H. Møller, T. Möller, A. Verdecchia, R. Capocaccia, G. Gatta, A. Micheli, M. Santaquilani, P. Roazzi, D. Lisi, W. Oberaigner, M. JechovaM. Rousarova, H. H. Storm, T. Aareleid, T. Hakulinen, G. Hédelin, I. Tron, E. Le Gall, G. Launoy, J. Macé-Lesech, J. Faivre, G. Chaplain, P. M. Carli, A. Danzon, B. Tretarre, M. Colonna, B. Lacour, N. Raverdy, C. Berger, F. Freycon, P. Grosclaude, J. Estève, P. Kaatsch, H. Ziegler, D. Hölzel, G. Schubert Fritschle, L. Tryggvadottir, F. Berrino, C. Allemani, P. Baili, L. Ciccolallo, G. Gatta, A. Micheli, M. Sant, E. Taussig, R. Capocaccia, E. Carrani, R. De Angelis, S. Hartley, P. Roazzi, M. Santaquilani, A. Tavilla, F. Valente, A. Verdecchia, S. Ferretti, P. Crosignani, P. Contiero, E. Conti, M. Vercelli, F. Pannelli, S. Vitarelli, F. Pannelli, P. Mosciatti, M. Federico, M. E. Artioli, M. Ponz De Leon, P. Benatti, V. De Lisi, L. Serventi, R. Zanetti, S. Patriarca, C. Magnani, G. Pastore, L. Gafà, R. Tumino, F. Falcini, M. Budroni, E. Paci, E. Crocetti, P. Zambon, S. Guzzinati, M. Dalmas, F. Langmark, A. Andersen, J. Rachtan, M. Bielska-Lasota, Z. Wronkowski, M. Zwierko, P. S. Pinheiro, I. Pleško, A. Obsitníková, V. Pompe-Kirn, I. Izarzugaza, C. Martinez-Garcia, I. Garau, C. Navarro, M. D. Chirlaque, E. Ardanaz, C. Moreno, J. Galceran, A. Torrella, R. Peris-Bonet, L. Barlow, T. Möller, G. Jundt, J. M. Lutz, M. Usel, J. W.W. Coebergh, A. Van Der Does-Van Den Berg, O. Visser, S. Godward, M. P. Coleman, E. M.I. Williams, D. Forman, M. J. Quinn, M. Roche, S. Edwards, C. Stiller, J. Verne, J. Bell, J. L. Botha, G. Lawrence, R. Black, D. Brewster, J. A. Steward

Research output: Contribution to journalArticle

545 Citations (Scopus)

Abstract

EUROCARE-3 analysed the survival of 1 815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries. The results are reported in tables, one per cancer site, coded according to the International Classification of Diseases (ICD)-9 classification. The main findings of the tables are summarised and commented on in this article. For most solid cancers, wide differences in survival between different European populations were found, as also reported by EUROCARE-1 and EUROCARE-2, despite a remarkable (10%) overall increase in cancer survival from 1985 to 1994. Survival was highest in northern Europe (Sweden, Norway, Finland and Iceland), and fairly good in central-southern Europe (France, Switzerland, Austria and Spain). Survival was particularly low in eastern Europe, low in Denmark and the UK, and fairly low in Portugal and Malta. The mix of tumour stage at diagnosis explains much of the survival differences for cancers of the digestive tract, female reproductive system, breast, thyroid, and also skin melanoma. For tumours of the urinary tract and prostate, the differences were explained mainly by differences in diagnostic criteria and procedures. The case mix by anatomic subsite largely explains differences in survival for head and neck cancers. For oesophagus, pancreas, liver and brain cancer, with poor prognoses, survival differences were limited. Tumours, for which highly effective treatments are available, such as testicular cancer, Hodgkin's lymphoma and some haematological malignancies, had fairly uniform survival across Europe. Survival for all tumours combined (an indicator of the overall cancer care performance of a nation's health system) was better in young than old patients, and better in women than men. The affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes.

Original languageEnglish (US)
JournalAnnals of Oncology
Volume14
Issue numberSUPPL.5
DOIs
StatePublished - Dec 1 2003
Externally publishedYes

Fingerprint

Survival
Neoplasms
Malta
Iceland
Eastern Europe
Portugal
Austria
Diagnosis-Related Groups
Testicular Neoplasms
International Classification of Diseases
Hematologic Neoplasms
Denmark
Finland
Norway
Liver Neoplasms
Head and Neck Neoplasms
Urinary Tract
Switzerland
Hodgkin Disease
Pancreatic Neoplasms

Keywords

  • Age-standardised relative survival
  • Cancer survival
  • Europe
  • International comparison
  • Population-based cancer registries

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Sant, M., Aareleid, T., Berrino, F., Bielska Lasota, M., Carli, P. M., Faivre, J., ... Steward, J. A. (2003). EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - Results and commentary. Annals of Oncology, 14(SUPPL.5). https://doi.org/10.1093/annonc/mdg754

EUROCARE-3 : Survival of cancer patients diagnosed 1990-94 - Results and commentary. / Sant, M.; Aareleid, T.; Berrino, F.; Bielska Lasota, M.; Carli, P. M.; Faivre, J.; Grosclaude, P.; Hédelin, G.; Matsuda, T.; Møller, H.; Möller, T.; Verdecchia, A.; Capocaccia, R.; Gatta, G.; Micheli, A.; Santaquilani, M.; Roazzi, P.; Lisi, D.; Oberaigner, W.; Jechova, M.; Rousarova, M.; Storm, H. H.; Aareleid, T.; Hakulinen, T.; Hédelin, G.; Tron, I.; Le Gall, E.; Launoy, G.; Macé-Lesech, J.; Faivre, J.; Chaplain, G.; Carli, P. M.; Danzon, A.; Tretarre, B.; Colonna, M.; Lacour, B.; Raverdy, N.; Berger, C.; Freycon, F.; Grosclaude, P.; Estève, J.; Kaatsch, P.; Ziegler, H.; Hölzel, D.; Schubert Fritschle, G.; Tryggvadottir, L.; Berrino, F.; Allemani, C.; Baili, P.; Ciccolallo, L.; Gatta, G.; Micheli, A.; Sant, M.; Taussig, E.; Capocaccia, R.; Carrani, E.; De Angelis, R.; Hartley, S.; Roazzi, P.; Santaquilani, M.; Tavilla, A.; Valente, F.; Verdecchia, A.; Ferretti, S.; Crosignani, P.; Contiero, P.; Conti, E.; Vercelli, M.; Pannelli, F.; Vitarelli, S.; Pannelli, F.; Mosciatti, P.; Federico, M.; Artioli, M. E.; Ponz De Leon, M.; Benatti, P.; De Lisi, V.; Serventi, L.; Zanetti, R.; Patriarca, S.; Magnani, C.; Pastore, G.; Gafà, L.; Tumino, R.; Falcini, F.; Budroni, M.; Paci, E.; Crocetti, E.; Zambon, P.; Guzzinati, S.; Dalmas, M.; Langmark, F.; Andersen, A.; Rachtan, J.; Bielska-Lasota, M.; Wronkowski, Z.; Zwierko, M.; Pinheiro, P. S.; Pleško, I.; Obsitníková, A.; Pompe-Kirn, V.; Izarzugaza, I.; Martinez-Garcia, C.; Garau, I.; Navarro, C.; Chirlaque, M. D.; Ardanaz, E.; Moreno, C.; Galceran, J.; Torrella, A.; Peris-Bonet, R.; Barlow, L.; Möller, T.; Jundt, G.; Lutz, J. M.; Usel, M.; Coebergh, J. W.W.; Van Der Does-Van Den Berg, A.; Visser, O.; Godward, S.; Coleman, M. P.; Williams, E. M.I.; Forman, D.; Quinn, M. J.; Roche, M.; Edwards, S.; Stiller, C.; Verne, J.; Bell, J.; Botha, J. L.; Lawrence, G.; Black, R.; Brewster, D.; Steward, J. A.

In: Annals of Oncology, Vol. 14, No. SUPPL.5, 01.12.2003.

Research output: Contribution to journalArticle

Sant, M, Aareleid, T, Berrino, F, Bielska Lasota, M, Carli, PM, Faivre, J, Grosclaude, P, Hédelin, G, Matsuda, T, Møller, H, Möller, T, Verdecchia, A, Capocaccia, R, Gatta, G, Micheli, A, Santaquilani, M, Roazzi, P, Lisi, D, Oberaigner, W, Jechova, M, Rousarova, M, Storm, HH, Aareleid, T, Hakulinen, T, Hédelin, G, Tron, I, Le Gall, E, Launoy, G, Macé-Lesech, J, Faivre, J, Chaplain, G, Carli, PM, Danzon, A, Tretarre, B, Colonna, M, Lacour, B, Raverdy, N, Berger, C, Freycon, F, Grosclaude, P, Estève, J, Kaatsch, P, Ziegler, H, Hölzel, D, Schubert Fritschle, G, Tryggvadottir, L, Berrino, F, Allemani, C, Baili, P, Ciccolallo, L, Gatta, G, Micheli, A, Sant, M, Taussig, E, Capocaccia, R, Carrani, E, De Angelis, R, Hartley, S, Roazzi, P, Santaquilani, M, Tavilla, A, Valente, F, Verdecchia, A, Ferretti, S, Crosignani, P, Contiero, P, Conti, E, Vercelli, M, Pannelli, F, Vitarelli, S, Pannelli, F, Mosciatti, P, Federico, M, Artioli, ME, Ponz De Leon, M, Benatti, P, De Lisi, V, Serventi, L, Zanetti, R, Patriarca, S, Magnani, C, Pastore, G, Gafà, L, Tumino, R, Falcini, F, Budroni, M, Paci, E, Crocetti, E, Zambon, P, Guzzinati, S, Dalmas, M, Langmark, F, Andersen, A, Rachtan, J, Bielska-Lasota, M, Wronkowski, Z, Zwierko, M, Pinheiro, PS, Pleško, I, Obsitníková, A, Pompe-Kirn, V, Izarzugaza, I, Martinez-Garcia, C, Garau, I, Navarro, C, Chirlaque, MD, Ardanaz, E, Moreno, C, Galceran, J, Torrella, A, Peris-Bonet, R, Barlow, L, Möller, T, Jundt, G, Lutz, JM, Usel, M, Coebergh, JWW, Van Der Does-Van Den Berg, A, Visser, O, Godward, S, Coleman, MP, Williams, EMI, Forman, D, Quinn, MJ, Roche, M, Edwards, S, Stiller, C, Verne, J, Bell, J, Botha, JL, Lawrence, G, Black, R, Brewster, D & Steward, JA 2003, 'EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - Results and commentary', Annals of Oncology, vol. 14, no. SUPPL.5. https://doi.org/10.1093/annonc/mdg754
Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J et al. EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - Results and commentary. Annals of Oncology. 2003 Dec 1;14(SUPPL.5). https://doi.org/10.1093/annonc/mdg754
Sant, M. ; Aareleid, T. ; Berrino, F. ; Bielska Lasota, M. ; Carli, P. M. ; Faivre, J. ; Grosclaude, P. ; Hédelin, G. ; Matsuda, T. ; Møller, H. ; Möller, T. ; Verdecchia, A. ; Capocaccia, R. ; Gatta, G. ; Micheli, A. ; Santaquilani, M. ; Roazzi, P. ; Lisi, D. ; Oberaigner, W. ; Jechova, M. ; Rousarova, M. ; Storm, H. H. ; Aareleid, T. ; Hakulinen, T. ; Hédelin, G. ; Tron, I. ; Le Gall, E. ; Launoy, G. ; Macé-Lesech, J. ; Faivre, J. ; Chaplain, G. ; Carli, P. M. ; Danzon, A. ; Tretarre, B. ; Colonna, M. ; Lacour, B. ; Raverdy, N. ; Berger, C. ; Freycon, F. ; Grosclaude, P. ; Estève, J. ; Kaatsch, P. ; Ziegler, H. ; Hölzel, D. ; Schubert Fritschle, G. ; Tryggvadottir, L. ; Berrino, F. ; Allemani, C. ; Baili, P. ; Ciccolallo, L. ; Gatta, G. ; Micheli, A. ; Sant, M. ; Taussig, E. ; Capocaccia, R. ; Carrani, E. ; De Angelis, R. ; Hartley, S. ; Roazzi, P. ; Santaquilani, M. ; Tavilla, A. ; Valente, F. ; Verdecchia, A. ; Ferretti, S. ; Crosignani, P. ; Contiero, P. ; Conti, E. ; Vercelli, M. ; Pannelli, F. ; Vitarelli, S. ; Pannelli, F. ; Mosciatti, P. ; Federico, M. ; Artioli, M. E. ; Ponz De Leon, M. ; Benatti, P. ; De Lisi, V. ; Serventi, L. ; Zanetti, R. ; Patriarca, S. ; Magnani, C. ; Pastore, G. ; Gafà, L. ; Tumino, R. ; Falcini, F. ; Budroni, M. ; Paci, E. ; Crocetti, E. ; Zambon, P. ; Guzzinati, S. ; Dalmas, M. ; Langmark, F. ; Andersen, A. ; Rachtan, J. ; Bielska-Lasota, M. ; Wronkowski, Z. ; Zwierko, M. ; Pinheiro, P. S. ; Pleško, I. ; Obsitníková, A. ; Pompe-Kirn, V. ; Izarzugaza, I. ; Martinez-Garcia, C. ; Garau, I. ; Navarro, C. ; Chirlaque, M. D. ; Ardanaz, E. ; Moreno, C. ; Galceran, J. ; Torrella, A. ; Peris-Bonet, R. ; Barlow, L. ; Möller, T. ; Jundt, G. ; Lutz, J. M. ; Usel, M. ; Coebergh, J. W.W. ; Van Der Does-Van Den Berg, A. ; Visser, O. ; Godward, S. ; Coleman, M. P. ; Williams, E. M.I. ; Forman, D. ; Quinn, M. J. ; Roche, M. ; Edwards, S. ; Stiller, C. ; Verne, J. ; Bell, J. ; Botha, J. L. ; Lawrence, G. ; Black, R. ; Brewster, D. ; Steward, J. A. / EUROCARE-3 : Survival of cancer patients diagnosed 1990-94 - Results and commentary. In: Annals of Oncology. 2003 ; Vol. 14, No. SUPPL.5.
@article{0d2a7e72586f46718bab1bb43213c7f5,
title = "EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - Results and commentary",
abstract = "EUROCARE-3 analysed the survival of 1 815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries. The results are reported in tables, one per cancer site, coded according to the International Classification of Diseases (ICD)-9 classification. The main findings of the tables are summarised and commented on in this article. For most solid cancers, wide differences in survival between different European populations were found, as also reported by EUROCARE-1 and EUROCARE-2, despite a remarkable (10{\%}) overall increase in cancer survival from 1985 to 1994. Survival was highest in northern Europe (Sweden, Norway, Finland and Iceland), and fairly good in central-southern Europe (France, Switzerland, Austria and Spain). Survival was particularly low in eastern Europe, low in Denmark and the UK, and fairly low in Portugal and Malta. The mix of tumour stage at diagnosis explains much of the survival differences for cancers of the digestive tract, female reproductive system, breast, thyroid, and also skin melanoma. For tumours of the urinary tract and prostate, the differences were explained mainly by differences in diagnostic criteria and procedures. The case mix by anatomic subsite largely explains differences in survival for head and neck cancers. For oesophagus, pancreas, liver and brain cancer, with poor prognoses, survival differences were limited. Tumours, for which highly effective treatments are available, such as testicular cancer, Hodgkin's lymphoma and some haematological malignancies, had fairly uniform survival across Europe. Survival for all tumours combined (an indicator of the overall cancer care performance of a nation's health system) was better in young than old patients, and better in women than men. The affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes.",
keywords = "Age-standardised relative survival, Cancer survival, Europe, International comparison, Population-based cancer registries",
author = "M. Sant and T. Aareleid and F. Berrino and {Bielska Lasota}, M. and Carli, {P. M.} and J. Faivre and P. Grosclaude and G. H{\'e}delin and T. Matsuda and H. M{\o}ller and T. M{\"o}ller and A. Verdecchia and R. Capocaccia and G. Gatta and A. Micheli and M. Santaquilani and P. Roazzi and D. Lisi and W. Oberaigner and M. Jechova and M. Rousarova and Storm, {H. H.} and T. Aareleid and T. Hakulinen and G. H{\'e}delin and I. Tron and {Le Gall}, E. and G. Launoy and J. Mac{\'e}-Lesech and J. Faivre and G. Chaplain and Carli, {P. M.} and A. Danzon and B. Tretarre and M. Colonna and B. Lacour and N. Raverdy and C. Berger and F. Freycon and P. Grosclaude and J. Est{\`e}ve and P. Kaatsch and H. Ziegler and D. H{\"o}lzel and {Schubert Fritschle}, G. and L. Tryggvadottir and F. Berrino and C. Allemani and P. Baili and L. Ciccolallo and G. Gatta and A. Micheli and M. Sant and E. Taussig and R. Capocaccia and E. Carrani and {De Angelis}, R. and S. Hartley and P. Roazzi and M. Santaquilani and A. Tavilla and F. Valente and A. Verdecchia and S. Ferretti and P. Crosignani and P. Contiero and E. Conti and M. Vercelli and F. Pannelli and S. Vitarelli and F. Pannelli and P. Mosciatti and M. Federico and Artioli, {M. E.} and {Ponz De Leon}, M. and P. Benatti and {De Lisi}, V. and L. Serventi and R. Zanetti and S. Patriarca and C. Magnani and G. Pastore and L. Gaf{\`a} and R. Tumino and F. Falcini and M. Budroni and E. Paci and E. Crocetti and P. Zambon and S. Guzzinati and M. Dalmas and F. Langmark and A. Andersen and J. Rachtan and M. Bielska-Lasota and Z. Wronkowski and M. Zwierko and Pinheiro, {P. S.} and I. Pleško and A. Obsitn{\'i}kov{\'a} and V. Pompe-Kirn and I. Izarzugaza and C. Martinez-Garcia and I. Garau and C. Navarro and Chirlaque, {M. D.} and E. Ardanaz and C. Moreno and J. Galceran and A. Torrella and R. Peris-Bonet and L. Barlow and T. M{\"o}ller and G. Jundt and Lutz, {J. M.} and M. Usel and Coebergh, {J. W.W.} and {Van Der Does-Van Den Berg}, A. and O. Visser and S. Godward and Coleman, {M. P.} and Williams, {E. M.I.} and D. Forman and Quinn, {M. J.} and M. Roche and S. Edwards and C. Stiller and J. Verne and J. Bell and Botha, {J. L.} and G. Lawrence and R. Black and D. Brewster and Steward, {J. A.}",
year = "2003",
month = "12",
day = "1",
doi = "10.1093/annonc/mdg754",
language = "English (US)",
volume = "14",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "SUPPL.5",

}

TY - JOUR

T1 - EUROCARE-3

T2 - Survival of cancer patients diagnosed 1990-94 - Results and commentary

AU - Sant, M.

AU - Aareleid, T.

AU - Berrino, F.

AU - Bielska Lasota, M.

AU - Carli, P. M.

AU - Faivre, J.

AU - Grosclaude, P.

AU - Hédelin, G.

AU - Matsuda, T.

AU - Møller, H.

AU - Möller, T.

AU - Verdecchia, A.

AU - Capocaccia, R.

AU - Gatta, G.

AU - Micheli, A.

AU - Santaquilani, M.

AU - Roazzi, P.

AU - Lisi, D.

AU - Oberaigner, W.

AU - Jechova, M.

AU - Rousarova, M.

AU - Storm, H. H.

AU - Aareleid, T.

AU - Hakulinen, T.

AU - Hédelin, G.

AU - Tron, I.

AU - Le Gall, E.

AU - Launoy, G.

AU - Macé-Lesech, J.

AU - Faivre, J.

AU - Chaplain, G.

AU - Carli, P. M.

AU - Danzon, A.

AU - Tretarre, B.

AU - Colonna, M.

AU - Lacour, B.

AU - Raverdy, N.

AU - Berger, C.

AU - Freycon, F.

AU - Grosclaude, P.

AU - Estève, J.

AU - Kaatsch, P.

AU - Ziegler, H.

AU - Hölzel, D.

AU - Schubert Fritschle, G.

AU - Tryggvadottir, L.

AU - Berrino, F.

AU - Allemani, C.

AU - Baili, P.

AU - Ciccolallo, L.

AU - Gatta, G.

AU - Micheli, A.

AU - Sant, M.

AU - Taussig, E.

AU - Capocaccia, R.

AU - Carrani, E.

AU - De Angelis, R.

AU - Hartley, S.

AU - Roazzi, P.

AU - Santaquilani, M.

AU - Tavilla, A.

AU - Valente, F.

AU - Verdecchia, A.

AU - Ferretti, S.

AU - Crosignani, P.

AU - Contiero, P.

AU - Conti, E.

AU - Vercelli, M.

AU - Pannelli, F.

AU - Vitarelli, S.

AU - Pannelli, F.

AU - Mosciatti, P.

AU - Federico, M.

AU - Artioli, M. E.

AU - Ponz De Leon, M.

AU - Benatti, P.

AU - De Lisi, V.

AU - Serventi, L.

AU - Zanetti, R.

AU - Patriarca, S.

AU - Magnani, C.

AU - Pastore, G.

AU - Gafà, L.

AU - Tumino, R.

AU - Falcini, F.

AU - Budroni, M.

AU - Paci, E.

AU - Crocetti, E.

AU - Zambon, P.

AU - Guzzinati, S.

AU - Dalmas, M.

AU - Langmark, F.

AU - Andersen, A.

AU - Rachtan, J.

AU - Bielska-Lasota, M.

AU - Wronkowski, Z.

AU - Zwierko, M.

AU - Pinheiro, P. S.

AU - Pleško, I.

AU - Obsitníková, A.

AU - Pompe-Kirn, V.

AU - Izarzugaza, I.

AU - Martinez-Garcia, C.

AU - Garau, I.

AU - Navarro, C.

AU - Chirlaque, M. D.

AU - Ardanaz, E.

AU - Moreno, C.

AU - Galceran, J.

AU - Torrella, A.

AU - Peris-Bonet, R.

AU - Barlow, L.

AU - Möller, T.

AU - Jundt, G.

AU - Lutz, J. M.

AU - Usel, M.

AU - Coebergh, J. W.W.

AU - Van Der Does-Van Den Berg, A.

AU - Visser, O.

AU - Godward, S.

AU - Coleman, M. P.

AU - Williams, E. M.I.

AU - Forman, D.

AU - Quinn, M. J.

AU - Roche, M.

AU - Edwards, S.

AU - Stiller, C.

AU - Verne, J.

AU - Bell, J.

AU - Botha, J. L.

AU - Lawrence, G.

AU - Black, R.

AU - Brewster, D.

AU - Steward, J. A.

PY - 2003/12/1

Y1 - 2003/12/1

N2 - EUROCARE-3 analysed the survival of 1 815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries. The results are reported in tables, one per cancer site, coded according to the International Classification of Diseases (ICD)-9 classification. The main findings of the tables are summarised and commented on in this article. For most solid cancers, wide differences in survival between different European populations were found, as also reported by EUROCARE-1 and EUROCARE-2, despite a remarkable (10%) overall increase in cancer survival from 1985 to 1994. Survival was highest in northern Europe (Sweden, Norway, Finland and Iceland), and fairly good in central-southern Europe (France, Switzerland, Austria and Spain). Survival was particularly low in eastern Europe, low in Denmark and the UK, and fairly low in Portugal and Malta. The mix of tumour stage at diagnosis explains much of the survival differences for cancers of the digestive tract, female reproductive system, breast, thyroid, and also skin melanoma. For tumours of the urinary tract and prostate, the differences were explained mainly by differences in diagnostic criteria and procedures. The case mix by anatomic subsite largely explains differences in survival for head and neck cancers. For oesophagus, pancreas, liver and brain cancer, with poor prognoses, survival differences were limited. Tumours, for which highly effective treatments are available, such as testicular cancer, Hodgkin's lymphoma and some haematological malignancies, had fairly uniform survival across Europe. Survival for all tumours combined (an indicator of the overall cancer care performance of a nation's health system) was better in young than old patients, and better in women than men. The affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes.

AB - EUROCARE-3 analysed the survival of 1 815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries. The results are reported in tables, one per cancer site, coded according to the International Classification of Diseases (ICD)-9 classification. The main findings of the tables are summarised and commented on in this article. For most solid cancers, wide differences in survival between different European populations were found, as also reported by EUROCARE-1 and EUROCARE-2, despite a remarkable (10%) overall increase in cancer survival from 1985 to 1994. Survival was highest in northern Europe (Sweden, Norway, Finland and Iceland), and fairly good in central-southern Europe (France, Switzerland, Austria and Spain). Survival was particularly low in eastern Europe, low in Denmark and the UK, and fairly low in Portugal and Malta. The mix of tumour stage at diagnosis explains much of the survival differences for cancers of the digestive tract, female reproductive system, breast, thyroid, and also skin melanoma. For tumours of the urinary tract and prostate, the differences were explained mainly by differences in diagnostic criteria and procedures. The case mix by anatomic subsite largely explains differences in survival for head and neck cancers. For oesophagus, pancreas, liver and brain cancer, with poor prognoses, survival differences were limited. Tumours, for which highly effective treatments are available, such as testicular cancer, Hodgkin's lymphoma and some haematological malignancies, had fairly uniform survival across Europe. Survival for all tumours combined (an indicator of the overall cancer care performance of a nation's health system) was better in young than old patients, and better in women than men. The affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes.

KW - Age-standardised relative survival

KW - Cancer survival

KW - Europe

KW - International comparison

KW - Population-based cancer registries

UR - http://www.scopus.com/inward/record.url?scp=1542306709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542306709&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdg754

DO - 10.1093/annonc/mdg754

M3 - Article

C2 - 14684501

AN - SCOPUS:1542306709

VL - 14

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - SUPPL.5

ER -